Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

10.00
Delayed Data
As of Aug 17
 -0.01 / -0.10%
Today’s Change
6.78
Today|||52-Week Range
11.34
+24.84%
Year-to-Date

Stock Price Forecast

The 9 analysts offering 12-month price forecasts for Teva Pharmaceutical Industries Ltd have a median target of 10.00, with a high estimate of 13.00 and a low estimate of 8.00. The median estimate represents a 0.00% increase from the last price of 10.00.

Analyst Recommendations

The current consensus among 14 polled investment analysts is to Hold stock in Teva Pharmaceutical Industries Ltd. This rating has held steady since August, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.62
Sales
$3.9B
Reporting Date
Nov 03

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -8.35%
 
 
 
 
 
 
Growthannually -1.34%
 
 
 
 
 
 

Sales

Growthquarterly 1.78%
 
 
 
 
 
 
Growthannually -3.44%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.